Reduction of O-Linked N-Acetylglucosamine-Modified Assembly Protein-3 in Alzheimer’s Disease
Open accessThe DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.
Abstract
Abnormal protein processing and modification is associated with Alzheimer’s disease (AD) pathology. The role of phosphorylation in AD has been studied extensively because the presumed abnormal phosphorylation of tau protein is believed to play a role in the formation of paired helical filaments. Glycosylation with O-linked N-acetylglucosamine (O-GlcNAc) to serine and threonine residues is a dynamic protein modification of intracellular proteins, and it shares similar features with protein phosphorylation. In this study,O-GlcNAc glycosylation of proteins from autopsied human brains with confirmed AD and non-AD age-matched controls was examined.O-GlcNAcylation was demonstrated by labeling protein extracts with [3 H]galactose in the presence of galactosyltransferase and subsequent analyses of saccharide–protein linkage and saccharide structure. The number of O-GlcNAc-containing proteins and the overall O-GlcNAc level do not appear to be different between AD and control brain tissues. The only significant change observed is a marked reduction of O-GlcNAcylated clathrin assembly protein-3 (AP-3) in AD. The reduction is more evident in brain neocortical regions, and there appears to be a negative correlation between O-glycosylated AP-3 and the density of neurofibrillary tangles. These data suggest a possible association between the O-glycosylated AP-3 and AD pathology.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Neurofibrillary tangles but not senile plaques parallel duration and severity of Alzheimer's disease
Arriagada, P. V., Growdon, J. H., Hedley-Whyte, E. T., & Hyman, B. T. (1992) · Neurology · doi:10.1212/wnl.42.3.631 · Cited by 2,668
Observations on the brains of demented old people
Tomlinson, B. E., Blessed, G., & Roth, M. (1970) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(70)90063-8 · Cited by 2,084
Life and Death of Neurons in the Aging Brain
Morrison, J. H., & Hof, P. R. (1997) · Science · doi:10.1126/science.278.5337.412 · Cited by 1,344 · cited 2×
“Although other recent studies have shown major neuronal loss in selected regions of AD brain (for review, see Morrison and Hof, 1997 ), we did not sample from any of these selectively vulnerable regions.”
ResultBramblett, G. T., Goedert, M., Jakes, R., Merrick, S. E., Trojanowski, J. Q., & Lee, V. M. Y. (1993) · Neuron · doi:10.1016/0896-6273(93)90057-x · Cited by 903 · cited 2×
“2, 3), the range in which various tau isoforms migrate on SDS-PAGE gels (Greenberg and Davies, 1990; Bramblett et al., 1993).”
BackgroundQuantitative assessment of cortical synaptic density in Alzheimer's disease
Scheff, S. W., DeKosky, S. T., & Price, D. A. (1990) · Neurobiology of Aging · doi:10.1016/0197-4580(90)90059-9 · Cited by 446 · cited 2×
“Because AP-3 is a synaptic protein associated with clathrincoated vesicles (Lindner and Ungewickell, 1992; Zhou et al., 1993; Lafer et al., 1997), the decline of this glycoprotein may be part of the synapse loss that occurs in AD. In fact, electron microscopic ( Scheff et al., 1990; Scheff and Price, 1993) and immuno-…”
BackgroundThe Microtubule-associated Protein Tau Is Extensively Modified with O-linked N-acetylglucosamine
Arnold, C. S., Johnson, G. W., Cole, R. N., Dong, D. L.-Y., Lee, M., & Hart, G. W. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.46.28741 · Cited by 361 · cited 5×
“That tau can be modified by O-GlcNAc has been demonstrated, albeit only on purified bovine tau (Arnold et al., 1996).”
BackgroundMethodInfluentialWang, J.-Z., Grundke-Iqbal, I., & Iqbal, K. (1996) · Nature Medicine · doi:10.1038/nm0896-871 · Cited by 360
Structural relationships between clathrin assembly proteins from the Golgi and the plasma membrane.
Ahle, S., Mann, A., Eichelsbacher, U., & Ungewickell, E. (1988) · The EMBO Journal · doi:10.1002/j.1460-2075.1988.tb02897.x · Cited by 354 · cited 7×
“The same 3H-labeled samples were also immunoblotted with an antibody that specifically recognizes a subunit of another clathrin assembly protein, AP-2 (Ahle et al., 1988).”
BackgroundMethodInfluentialAnalysis of microtubule-associated protein tau glycation in paired helical filaments.
Ledesma, M. D., Bonay, P., Colaço, C., & Avila, J. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)31849-5 · Cited by 333 · cited 1×
“Recent observations of glycation and glycosylation products in AD brains (Ledesma et al., 1994; Griffith and Schmitz, 1995; Smith et al., 1995; Wang et al., 1996) suggest that protein modifications other than phosphorylation may also contribute to AD pathology.”
BackgroundClathrin assembly protein AP-3 is phosphorylated and glycosylated on the 50-kDa structural domain
Murphy, J. E., Hanover, J. A., Froehlich, M., DuBois, G., & Keen, J. H. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)31968-3 · Cited by 54
Cited by
Hart, G. W., Slawson, C., Ramirez-Correa, G., & Lagerlof, O. (2011) · Annual Review of Biochemistry · doi:10.1146/annurev-biochem-060608-102511 · Cited by 1,317
“Clathrin assembly proteins AP180 and AP-3 are O-GlcNAcylated in normal brain, and modification of these proteins is decreased in AD brains (207, 208).”
BackgroundShafi, R., Iyer, S. P. N., Ellies, L. G., O'Donnell, N., Marek, K. W., Chui, D., Hart, G. W., & Marth, J. D. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.100471497 · Cited by 794
Dynamic O-Glycosylation of Nuclear and Cytosolic Proteins
Gao, Y., Wells, L., Comer, F. I., Parker, G. J., & Hart, G. W. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m010420200 · Cited by 761
The Hexosamine Signaling Pathway: Deciphering the "O-GlcNAc Code"
Love, D. C., & Hanover, J. A. (2005) · Science's STKE · doi:10.1126/stke.3122005re13 · Cited by 461
ZACHARA, N. (2004) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2004.03.016 · Cited by 426
Metadata
- Authors
- Yao, P. J., & Coleman, P. D.
- Venue
- The Journal of Neuroscience
- Publisher
- Society for Neuroscience
- Published
- 1998-04-01
- Volume
- 18
- Issue
- 7
- Pages
- 2399-2411
- ISSN
- 0270-6474 (ISSN-L)
- 1529-2401
- OpenAlex
- W1504722292
- Cited by
- 85
- References
- 10
- FWCI
- 0.79
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Reduction of O-Linked N-Acetylglucosamine-Modified Assembly Protein-3 in Alzheimer’s Disease. https://app.cochat.ai/papers/10.1523/jneurosci.18-07-02399.1998
- The paper
- Yao, P. J., & Coleman, P. D. (1998). Reduction of O-Linked N-Acetylglucosamine-Modified Assembly Protein-3 in Alzheimer’s Disease. The Journal of Neuroscience. https://doi.org/10.1523/jneurosci.18-07-02399.1998
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.